The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Gardasil 9

0.5 millilitre(s) Suspension for injection

MSD VaccinsEU/1/15/1007/001-003

Main Information

Trade NameGardasil 9
Active SubstancesHpv type 31 l1 protein
Hpv type 33 l1 protein
Hpv 18 l1 protein
Hpv 16 l1 protein
Hpv type 11 l1 protein
Hpv type 52 l1 protein
Hpv type 6 l1 protein
Hpv type 58 l1 protein
Hpv type 45 l1 protein
Strength0.5 millilitre(s)
Dosage FormSuspension for injection
Licence HolderMSD Vaccins
Licence NumberEU/1/15/1007/001-003

Group Information



Licence Issued10/06/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back